Month: August 2017

The Lexington News Issue #1 — Q3/2017

Welcome the the “Lexington News” where we hope to inform you on our ongoing efforts to develop our HeartSentry device into a revolutionary, simple and effective technology for personalized measurement and monitoring of vascular health. Aimed at detecting the potential for cardiovascular disease at its earliest stages, we are working to commercialize HeartSentry as part

Read More

Lexington Biosciences Announces Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA – August 8 , 2017 – Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”), a development-stage medical device company operating within the healthcare industry, is pleased to announce a non-brokered private placement of up to

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News